Brevan Howard Capital Management LP Ironwood Pharmaceuticals Inc Transaction History
Brevan Howard Capital Management LP
- $11 Billion
- Q2 2024
A detailed history of Brevan Howard Capital Management LP transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 68,200 shares of IRWD stock, worth $280,302. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,200
Previous 28,974
135.38%
Holding current value
$280,302
Previous $252,000
76.19%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IRWD
# of Institutions
247Shares Held
171MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$88.6 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$67.4 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$38 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$36.6 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $630M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...